Kendall Marcus

Kendall Marcus

Company: FDA

Job title: Director, Division of Dermatology & Dental Products


Janus Kinase Inhibitors for Dermatologic Indications & Demonstrating Efficacy for Vitiligo 9:00 am

• Eaxming the role of Janus kinas inhibitors in treatment of patients with dermatologic diseases • Demonstrating favorable risk/benefit of JAKi in development programs • Reviewing the considerations for vitiligo product developmentRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.